| Financial Year |
March 31 2023 |
| Monetary Funds |
208,853,548.55 |
| Held-for-trading Financial Assets |
6,150,241.50 |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
140,400,660.95 |
| Advances to Suppliers |
11,559,184.55 |
| Other Receivables |
8,207,490.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
195,500,993.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,210,679.44 |
| Total Current Assets |
608,882,799.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,442,718.07 |
| Fixed Assetes |
151,922,087.31 |
| Under-construction Projects |
970,580,526.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,494,219.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,200,609.36 |
| Deferred Income Tax Assets |
13,753,580.71 |
| Other Non-Current Assets |
84,502,410.23 |
| Sub-Total of Non-Current Assets |
1,288,539,515.50 |
| Total Assets |
1,897,422,315.08 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
33,058,560.00 |
| Accounts Payable |
130,957,725.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,177,466.42 |
| Taxes Payable |
4,583,771.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
69,452,601.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
79,187,162.45 |
| Other Current Liabilities |
289,805.94 |
| Sub-Total of Current Liabilities |
350,844,395.14 |
| Long-term Loans |
203,480,200.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,144,787.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
261,594,164.60 |
| Total Liabilities |
612,438,559.74 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
419,540,457.16 |
| Surplus Reserve |
27,034,282.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
718,409,015.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,284,983,755.34 |
| Owner's Equity（Stockholder's Equity） |
1,284,983,755.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,897,422,315.08 |
